Dr. Imad Bitar, MD
Rheumatology (Rheumatology Physician)
104 Millsaps Dr
Hattiesburg, MS 39402
Who else practices at this address →
Forrest County is a federal mental health shortage area. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 29
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,280
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
MS license 20107
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Forrest General Hospital Hattiesburg, MS
- King's Daughters Medical Center-Brookhaven Brookhaven, MS
- South Central Reg Med Ctr Laurel, MS
- Merit Health Wesley Hattiesburg, MS
- Wayne General Hospital Waynesboro, MS
Medical groups
- Hattiesburg Clinic PA (537 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,280
- Services billed
- 296,695
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Injection, tocilizumab, 1 mg | 80,400 | 21 |
| Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 69,600 | 30 |
| Injection, denosumab, 1 mg | 25,500 | 322 |
| Injection, golimumab, 1 mg, for intravenous use | 25,440 | 41 |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 22,700 | 41 |
| Injection, romosozumab-aqqg, 1 mg | 10,710 | 17 |
| Injection, rituximab, 10 mg | 7,210 | 31 |
| Injection, infliximab, excludes biosimilar, 10 mg | 2,830 | 14 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 2,242 | 260 |
| Established patient office or other outpatient visit, 30-39 minutes | 1,089 | 659 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 176 payments worth $3,377 in total to this clinician.
| Amgen Inc. | $561 |
|---|---|
| AbbVie Inc. | $525 |
| Novartis Pharmaceuticals Corporation | $338 |
| GlaxoSmithKline, LLC. | $262 |
| Octapharma USA, Inc. | $225 |
| AstraZeneca Pharmaceuticals LP | $195 |
| UCB, Inc. | $170 |
| Radius Health, Inc. | $169 |
| Food and Beverage | $3,377 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.